CI
ALXN

Cigna Investments’s Alexion Pharmaceuticals ALXN Stock Holding History

Cigna Investments’s Portfolio ALXN Stock Details ALXN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-6,971
Closed -$1.28M – 776
2021
Q2 		$1.28M Sell
6,971
-906
-12% -$156K 0.09% 192
2021
Q1 		$1.21M Buy
7,877
+237
+3% +$36.7K 0.08% 225
2020
Q4 		$1.19M Buy
7,640
+519
+7% +$66.7K 0.09% 200
2020
Q3 		$814K Sell
7,121
-33
-0.5% -$3.56K 0.08% 233
2020
Q2 		$804K Buy
7,154
+928
+15% +$98.5K 0.08% 252
2020
Q1 		$559K Buy
6,226
+400
+7% +$39.3K 0.07% 297
2019
Q4 		$578K Sell
5,826
-755
-11% -$80.8K 0.06% 349
2019
Q3 		$694K Buy
6,581
+280
+4% +$31.6K 0.07% 316
2019
Q2 		$713K Sell
6,301
-81
-1% -$10.4K 0.08% 295
2019
Q1 		$863K Sell
6,382
-166
-3% -$20.6K 0.1% 256
2018
Q4 		$638K Sell
6,548
-17
-0.3% -$2.01K 0.05% 267
2018
Q3 		$736K Sell
6,565
-500
-7% -$62.7K 0.06% 254
2018
Q2 		$877K Sell
7,065
-1,034
-13% -$121K 0.06% 272
2018
Q1 		$902K Sell
8,099
-2,631
-25% -$314K 0.06% 275
2017
Q4 		$1.28M Sell
10,730
-368
-3% -$44.8K 0.08% 193
2017
Q3 		$1.56M Sell
11,098
-52
-0.5% -$7.07K 0.1% 146
2017
Q2 		$1.36M Buy
11,150
+1,936
+21% +$225K 0.09% 177
2017
Q1 		$1.12M Buy
9,214
+1,003
+12% +$129K 0.08% 245
2016
Q4 		$1M Buy
+8,211
New +$1M 0.11% 237

Other funds holding ALXN

BCI
Brinker Capital Investments Berwyn, Pennsylvania $11.7B AUM 21.33% 1-Year Est. Return
NICM
Neo Ivy Capital Management New York $379M AUM 28.34% 1-Year Est. Return
TAIM
TD Ameritrade Investment Management Omaha, Nebraska $9.4B AUM 7.2% 1-Year Est. Return
Barclays
Barclays London, United Kingdom $416B AUM 33.63% 1-Year Est. Return
RG
Retirement Group San Diego, California $279M AUM 22.21% 1-Year Est. Return
CFO
CVA Family Office Denver, Colorado $950M AUM 20.72% 1-Year Est. Return
MAM
Meeder Asset Management Dublin, Ohio $1.75B AUM 34.85% 1-Year Est. Return

Cigna Investments's ALXN Position: Q3 2021 in Review

Cigna Investments sold out of Alexion Pharmaceuticals (ALXN) in Q3 2021, closing a stake of 6,971 shares — an estimated $1.28M sold.

Cigna Investments first reported a position in ALXN in Q4 2016 and held it in 19 quarters. The position peaked at $1.56M in Q3 2017. 7 funds tracked by Wall St. Rank hold ALXN as of Q3 2021.

  • Cigna Investments reported no remaining Alexion Pharmaceuticals position as of Q3 2021 after selling out during the quarter.
  • Cigna Investments sold 6,971 Alexion Pharmaceuticals shares in Q3 2021, an estimated $1.28M.
  • Cigna Investments first reported a position in Alexion Pharmaceuticals in Q4 2016 and held it in 19 quarters.
  • Cigna Investments's Alexion Pharmaceuticals position peaked at $1.56M in Q3 2017.
  • 7 funds tracked by Wall St. Rank held Alexion Pharmaceuticals as of Q3 2021.

Based on Cigna Investments's 13F filing for Q3 2021, filed 12 Nov 2021.